Long-term study of sepsis patients after ICU care
Part of Infections clinical trials.
This study follows up with patients who had sepsis in the ICU to understand their long-term health outcomes. It may help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with sepsis or septic shock while in the ICU.
- You are 18 years or older.
- You or a family member agree to join the study.
- You do not have a life expectancy less than 3 months from other illnesses.
- You are willing to participate and not refuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
This study looks at the outcomes of people hospitalized with sepsis in China. It helps doctors understand how patients respond to treatment and what factors affect recovery.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study tests whether a simple written guide about sepsis can help you understand your condition and recovery better while you are in the ICU. If you qualify, you will receive the educational material and may be asked a few questions about your experience.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.